Bank of New York Mellon’s Opus Genetics IRD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$503K Buy
+122,479
New +$571K ﹤0.01% 3752
2023
Q2
Sell
-16,350
Closed -$61.3K 4471
2023
Q1
$61.3K Buy
+16,350
New +$58.7K ﹤0.01% 4164
2019
Q2
Sell
-241
Closed -$6K 4289
2019
Q1
$6K Sell
241
-7
-3% -$232 ﹤0.01% 4200
2018
Q4
$11K Hold
248
﹤0.01% 4189
2018
Q3
$21K Hold
248
﹤0.01% 4207
2018
Q2
$17K Sell
248
-93
-27% -$8.17K ﹤0.01% 4183
2018
Q1
$25K Buy
341
+47
+16% +$4.27K ﹤0.01% 4256
2017
Q4
$28K Buy
294
+46
+19% +$4.67K ﹤0.01% 4271
2017
Q3
$29K Sell
248
-36
-13% -$3.88K ﹤0.01% 4181
2017
Q2
$39K Buy
284
+19
+7% +$3.69K ﹤0.01% 4164
2017
Q1
$65K Buy
265
+17
+7% +$2.2K ﹤0.01% 4104
2016
Q4
$17K Sell
248
-15
-6% -$1.22K ﹤0.01% 4226
2016
Q3
$26K Sell
263
-40
-13% -$4.83K ﹤0.01% 4202
2016
Q2
$37K Hold
303
﹤0.01% 4228
2016
Q1
$48K Hold
303
﹤0.01% 4092
2015
Q4
$53K Hold
303
﹤0.01% 4175
2015
Q3
$76K Hold
303
﹤0.01% 4181
2015
Q2
$88K Buy
303
+36
+13% +$12.2K ﹤0.01% 4071
2015
Q1
$93K Hold
267
﹤0.01% 4059
2014
Q4
$90K Hold
267
﹤0.01% 4072
2014
Q3
$104K Hold
267
﹤0.01% 4043
2014
Q2
$111K Buy
267
+181
+210% +$82.3K ﹤0.01% 3975
2014
Q1
$45K Buy
+86
New +$46.5K ﹤0.01% 4088
2013
Q3
Sell
-319
Closed -$68K 4214
2013
Q2
$68K Buy
+319
New +$54.8K ﹤0.01% 3996

Other funds holding IRD

Bank of New York Mellon's IRD Position: Q2 2026 in Review

Bank of New York Mellon opened a new position in Opus Genetics (IRD) in Q2 2026: 122,479 shares worth $503K. The stake represents ﹤0.01% of the portfolio and ranks #3752 among its holdings. This is a return to the name: Bank of New York Mellon previously reported a position in IRD as recently as Q1 2023.

Bank of New York Mellon first reported a position in IRD in Q2 2013 and has held it in 24 quarters since. 27 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • Bank of New York Mellon held 122,479 shares of Opus Genetics worth $503K as of Q2 2026.
  • Opus Genetics was a new Bank of New York Mellon position in Q2 2026.
  • Opus Genetics made up ﹤0.01% of Bank of New York Mellon's portfolio in Q2 2026, its #3752 holding.
  • Bank of New York Mellon first reported a position in Opus Genetics in Q2 2013 and has held it in 24 quarters since.
  • 27 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.